envafolimab,lenvatinib
eisai,traconpharma,alphamab
[]
promising efficacy and safety demonstrated with envafolimab, lenvatinib, and tace in unresectable hcc #gi23 #hcc 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.